Position in IMVT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$88,552,513
-$57,540,167 QoQ
Shares Held
3,564,916
-38.0% QoQ
Ownership
1.74%
of shares outstanding
% of Portfolio
2.94%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMVT Over Time
Shares Held
Position Value (USD)
Derivatives in IMVT
reported options exposure · as of Mar 31, 2026CallValue
$47,196,000
CallShares
1,900,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $1,383,311,336 across 53 Biotechnology names. IMVT ranks #5 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
4,897,417 | $145,502,259 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
2,074,449 | $141,332,210 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
264,583 | $138,501,263 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,716,000 | $91,882,280 | |
| 5 | IMVT |
Immunovant, Inc.
This page
|
3,564,916 | $88,552,513 | |
| 6 | INCY |
Incyte Corp
|
656,817 | $61,819,616 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,175,110 | $57,564,744 | |
| 8 | CYTK |
Cytokinetics Inc
|
764,538 | $50,390,699 |
All Filings in IMVT
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,196,000 | 1,900,000 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $88,552,513 | 3,564,916 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $19,065,000 | 750,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $146,092,680 | 5,747,155 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $94,076,320 | 5,836,000 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $83,200,000 | 5,200,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $76,905,000 | 4,500,000 | Shares | Sole | 2025-05-15 | |
| 2025-03-31 | $15,381,000 | 900,000 | Call | Sole | 2025-05-15 | |
| 2024-12-31 | $33,439,500 | 1,350,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $95,874,415 | 3,870,586 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $101,153,480 | 3,548,000 | Shares | Sole | 2024-11-14 | |
| 2024-09-30 | $16,535,800 | 580,000 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $89,678,397 | 3,396,909 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $69,918,840 | 2,164,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $60,498,680 | 1,436,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $39,767,318 | 1,035,877 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||